Exane Derivatives Kala Pharmaceuticals, Inc. Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 30, 2021
SELL
$6.24 - $9.58 $87,746 - $134,713
-14,062 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$6.28 - $8.79 $57,725 - $80,797
9,192 Added 188.75%
14,062 $95,000
Q3 2020

Oct 06, 2020
BUY
$7.5 - $11.11 $18,750 - $27,775
2,500 Added 105.49%
4,870 $36,000
Q2 2020

Jul 10, 2020
BUY
$8.33 - $13.79 $19,742 - $32,682
2,370 New
2,370 $24,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.69M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email